The Bellamy's share price is up 72% in September

The Bellamy's Australia Ltd (ASX:BAL) share price has been on fire this month. Here's why…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The best performer on the benchmark index this month has been the Bellamy's Australia Ltd (ASX: BAL) share price by some distance.

Since the start of the month the infant formula company's shares have rocketed a massive 72% higher.

Why is the Bellamy's share price up 72% this month?

Investors were scrambling to buy the company's shares earlier this month when it received a surprise takeover approach from China Mengniu Dairy Company.

The offer went down well with management, leading to the two parties entering into a scheme implementation deed under which the Chinese dairy company will acquire 100% of the issued share capital of Bellamy's via a scheme of arrangement.

China Mengniu Dairy Company tabled an offer of $13.25 cash per share, comprising $12.65 cash per share and a $0.60 per share fully franked special dividend to be paid by Bellamy's prior to the implementation of the scheme.

This valued Bellamy's equity at approximately $1.5 billion and represented an enterprise value of 30 times reported normalised FY 2019 EBITDA. This was a 59% premium to the last close price at the time of $8.32 and a 54% premium to the three-month volume weighted average price to September 13 of $8.59.

Whilst this is admittedly a significant premium, it is worth remembering that the company's normalised EBITDA fell almost 34% last year due to delays in gaining the accreditation required to sell directly in the massive China market.

So if you believe this downturn was only transitory, then perhaps you wouldn't be overly ecstatic with the offer. Especially if you bought in when its shares were trading around the $22.00 mark in 2018.

Nevertheless, management appears happy with the deal. The Bellamy's board of directors has unanimously recommended that shareholders vote in favour of the scheme, in the absence of a superior proposal and subject to the independent expert's report. Each of its directors intend to vote all the Bellamy's shares they hold in favour of the scheme, subject to those same qualifications.

Bellamy's chief executive officer, Andrew Cohen, said: "Mengniu is a preeminent dairy company in China and an ideal partner for our business. It offers a strong platform for distribution and success in China, and a foundation for growth in the organic dairy and food industry in Australia."

"This transaction can further deliver on our founder's original vision of a truly iconic Australian brand and 'A Pure Start to Life' for the world. Our employees, our trade partners and local organic manufacturers will continue to grow and thrive with the success of our business," he added.

Whilst the deal will need to be given the approval of the Foreign Investment Review Board, the company appears confident it will be signed off. In light of this, it looks like a done deal.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »